• 1
    American Academy of Allergy, Asthma, and Immunology. Task force on allergic disorders. Executive Summary Report. Milwaukee, WI: American Academy of Allergy, Asthma, and Immunology, 1998;; accessed 1 June 2007.
  • 2
    Dykewicz M. 7. Rhinitis and sinusitis. J Allergy Clin Immunol 2003;111:520529.
  • 3
    Hewitt Associates LLC. The effects of allergies in the workplace. Lincolnshire, IL: Hewitt Associates, LLC, 1998.
  • 4
    Van Drunen C, Meltzer EO, Bachert C, Bousquet J, Fokkens WJ. Nasal allergies and beyond: a clinical review of the pharmacology, efficacy, and safety of mometasone furoate. Allergy 2005;60(Suppl. 80):519.
  • 5
    Ray NF, Baraniuk JN, Thamer M, Rinehart CS, Gergen PJ, Kaliner M et al. Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and other airway disorders. J Allergy Clin Immunol 1999;103(3 Pt 1):408414.
  • 6
    Van Cauwenberge P, Bachert C, Passalacqua G, Bousquet J, Canonica GW, Durham SR et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 2000;55:116134.
  • 7
    Takizawa H. Bronchial epithelial cells in allergic reactions. Curr Drug Targets Inflamm Allergy 2005;4:305311.
  • 8
    Holgate ST, Holloway J, Wilson S, Bucchieri F, Puddicombe S, Davies DE. Epithelial-mesenchymal communication in the pathogenesis of chronic asthma. Proc Am Thorac Soc 2004;1:9398.
  • 9
    Asokananthan N, Graham PT, Stewart DJ, Bakker AJ, Eidne KA, Thompson PJ et al. House dust mite allergens induce proinflammatory cytokines from respiratory epithelial cells: the cysteine protease allergen, Der p 1, activates protease-activated receptor (PAR)-2 and inactivates PAR-1. J Immunol 2002;169:4572.
  • 10
    Mutsaers SE, Bishop JE, McGrouther G, Laurent GJ. Mechanisms of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol 1997;29:517.
  • 11
    Asokananthan N, Graham PT, Fink J, Knight DA, Bakker AJ, McWilliam AS et al. Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells. J Immunol 2002;168:35773585.
  • 12
    Cromwell O, Hamid Q, Corrigan CJ, Barkans J, Meng Q, Collins PD et al. Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha. Immunology 1992;77:330337.
  • 13
    Cocks TM, Moffatt JD. Protease-activated receptor-2 (PAR2) in the airways. Pulm Pharmacol Ther 2001;14:183191.
  • 14
    Hong JH, Lee SI, Kim KE, Yong TS, Seo JT, Sohn MH et al. German cockroach extract activates protease-activated receptor 2 in human airway epithelial cells. J Allergy Clin Immunol 2004;113:315319.
  • 15
    Shin SH, Lee YH, Jeon CH. Protease-dependent activation of nasal polyp epithelial cells by airborne fungi leads to migration of eosinophils and neutrophils. Acta Otolaryngol 2006;126:12861294.
  • 16
    Birks EJ, Burton PBJ, Owen V, Mullen AJ, Hunt D, Banner NR et al. Elevated tumor necrosis factor-{alpha} and interleukin-6 in myocardium and serum of malfunctioning donor hearts. Circulation 2000;102:352III.
  • 17
    Dolganov GM, Woodruff PG, Novikov AA, Zhang Y, Ferrando RE, Szubin R et al. A novel method of gene transcript profiling in airway biopsy homogenates reveals increased expression of a Na+-K+-Cl cotransporter (NKCC1) in asthmatic subjects. Genome Res 2001;11:1473.
  • 18
    Magner WJ, Kazim AL, Stewart C, Romano MA, Catalano G, Grande C et al. Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors. J Immunol 2000;165:7017.
  • 19
    Brabender J, Lord RV, Wickramasinghe K, Metzger R, Schneider PM, Park JM et al. Glutathione S-transferase-pi expression is downregulated in patients with barrett’s esophagus and esophageal adenocarcinoma. J Gastrointest Surg 2002;6:359367.
  • 20
    Kovacs EJ. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today 1991;12:1723.
  • 21
    Raeburn D, Webber SE. Proinflammatory potential of the airway epithelium in bronchial asthma. Eur Respir J 1994;7:22262233.
  • 22
    Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Jasmin C, Canonica GW, Azzarone B. IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts. Int Immunol 1998;10:14211433.
  • 23
    Phillips DJ. Activins, inhibins and follistatins in the large domestic species. Domest Anim Endocrinol 2005;28:116.
  • 24
    Baruah P, Dumitriu IE, Peri G, Russo V, Mantovani A, Manfredi AA et al. The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells. J Leukoc Biol 2006;80:8795.
  • 25
    Molnar J, Fong KS, He QP, Hayashi K, Kim Y, Fong SF et al. Structural and functional diversity of lysyl oxidase and the LOX-like proteins. Biochim Biophys Acta 2003;1647:220224.
  • 26
    Fichtner-Feigl S, Strober W, Kawakami K, Puri RK, Kitani A. IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med 2006;12:99106.
  • 27
    Janes KA, Gaudet S, Albeck JG, Nielsen UB, Lauffenburger DA, Sorger PK. The response of human epithelial cells to TNF involves an inducible autocrine cascade. Cell 2006;124:12251239.
  • 28
    Russo C, Polosa R. TNF-alpha as a promising therapeutic target in chronic asthma: a lesson from rheumatoid arthritis. Clin Sci (Lond) 2005;109:135142.
  • 29
    Thomas PS. Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma. Immunol Cell Biol 2001;79:132140.
    Direct Link:
  • 30
    Lilly CM, Tateno H, Oguma T, Israel E, Sonna LA. Effects of allergen challenge on airway epithelial cell gene expression. Am J Respir Crit Care Med 2005;171:579586.